Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Antonelli

Showing results (221-230 of 246) with videos related to

Pageof 25
Sort By:
Haematologica|July 1, 1992
In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemiaL Catani, L Gugliotta, G Zauli, et al.
AIDS Research and Human Retroviruses|October 29, 2000
Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapyA Isgrò, I Mezzaroma, A Aiuti, et al.
International Journal of Immunopharmacology|January 1, 1991
The combined treatment of human peripheral blood mononuclear cells with thymolymphotropin and interleukin 2 increases PPD-driven T-cell proliferation and IL-2 induced cellular cytotoxicity against HIV-infected cellsA M Di Massimo, M S Gilardini Montani, M S Gilardini, et al.
Medical Microbiology and Immunology|August 13, 2008
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patientsE Riva, F Maggi, F Abbruzzese, et al.
Journal of Viral Hepatitis|August 7, 2012
Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patientsE Riva, C Scagnolari, K Monteleone, et al.
Antiviral Research|May 1, 1996
New arylpyrido-diazepine and -thiodiazepine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptaseD Bellarosa, G Antonelli, F Bambacioni, et al.
International Journal of Immunopathology and Pharmacology|February 20, 2003
Reverse transcriptase mutations in HIV-1 infected patients treated with two nucleoside analogues: the SMART studyN. Gianotti, M. Setti, P. E. Manconi, et al.
Scientific Reports|May 20, 2022
Machine learning phenomics (MLP) combining deep learning with time-lapse-microscopy for monitoring colorectal adenocarcinoma cells gene expression and drug-responseM D'Orazio, M Murdocca, A Mencattini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2011
Xenotropic murine leukaemia virus-related virus is not found in peripheral blood cells from treatment-naive human immunodeficiency virus-positive patientsF Maggi, D Focosi, L Lanini, et al.
Clinical and Experimental Immunology|January 17, 2007
Expression of biomarkers of interferon type I in patients suffering from chronic diseasesC Scagnolari, F Bellomi, S Trombetti, et al.
Pageof 25

Showing results (221-230 of 246) with videos related to

Sort By:
Pageof 25
Haematologica|July 1, 1992
In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemiaL Catani, L Gugliotta, G Zauli, et al.
AIDS Research and Human Retroviruses|October 29, 2000
Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapyA Isgrò, I Mezzaroma, A Aiuti, et al.
International Journal of Immunopharmacology|January 1, 1991
The combined treatment of human peripheral blood mononuclear cells with thymolymphotropin and interleukin 2 increases PPD-driven T-cell proliferation and IL-2 induced cellular cytotoxicity against HIV-infected cellsA M Di Massimo, M S Gilardini Montani, M S Gilardini, et al.
Medical Microbiology and Immunology|August 13, 2008
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patientsE Riva, F Maggi, F Abbruzzese, et al.
Journal of Viral Hepatitis|August 7, 2012
Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patientsE Riva, C Scagnolari, K Monteleone, et al.
Antiviral Research|May 1, 1996
New arylpyrido-diazepine and -thiodiazepine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptaseD Bellarosa, G Antonelli, F Bambacioni, et al.
International Journal of Immunopathology and Pharmacology|February 20, 2003
Reverse transcriptase mutations in HIV-1 infected patients treated with two nucleoside analogues: the SMART studyN. Gianotti, M. Setti, P. E. Manconi, et al.
Scientific Reports|May 20, 2022
Machine learning phenomics (MLP) combining deep learning with time-lapse-microscopy for monitoring colorectal adenocarcinoma cells gene expression and drug-responseM D'Orazio, M Murdocca, A Mencattini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2011
Xenotropic murine leukaemia virus-related virus is not found in peripheral blood cells from treatment-naive human immunodeficiency virus-positive patientsF Maggi, D Focosi, L Lanini, et al.
Clinical and Experimental Immunology|January 17, 2007
Expression of biomarkers of interferon type I in patients suffering from chronic diseasesC Scagnolari, F Bellomi, S Trombetti, et al.
Pageof 25